XML 35 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Liquidity - Additional Information (Detail) - USD ($)
9 Months Ended
Jan. 19, 2024
Aug. 29, 2023
Jan. 17, 2023
Sep. 30, 2024
Sep. 30, 2023
Jul. 11, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Net loss       $ 5,923,600 $ 5,687,500  
Accumulated deficit       102,850,000    
Cash used in operating activities       6,660,000 $ 3,817,000  
Proceeds from public equity offering $ 5,400,000 $ 3,900,000 $ 5,700,000      
Sale of stock number of shares issued in transaction 1,354,218 5,413,334 13,169,074      
Sales of prefunded warrants 224,730 1,920,000 6,830,926      
Price per share $ 3.8 $ 0.6 $ 0.325      
Per sale price of warrants $ 3.7999 $ 0.5999 $ 0.3249      
Amount borrowed against account receivable           $ 4,000,000
Line Of Credit Facility Maximum Borrowing Capacity           $ 900,000
Sale of stock consideration received on transaction $ 5,400,000 $ 3,900,000 $ 5,700,000      
Maximum [Member]            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Line Of Credit Facility Maximum Borrowing Capacity       $ 900,000